- In January 2024, FUJIFILM Diosynth Biotechnologies (U.S.) and SHL Medical (Switzerland) entered a strategic partnership to meet the increasing market demand for autoinjector medicines. The collaboration will enhance FUJIFILM's production capacity in Denmark, reaching up to 30 million units annually by early 2025. By integrating SHL's Molly autoinjector platform, the partnership aims to streamline production processes and reduce supply chain risks. This development will benefit pharmaceutical and biotech companies by providing quicker timelines to market and improving patient access to self-injection medications
